¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"subunit vaccine"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® vaccine ÇÑ±Û ¹é½Å
¼³¸í   
  Àü¿°º´¿¡ ´ëÇÏ¿© ÀΰøÀûÀ¸·Î ¸é¿ªÀ» ÁÖ±â À§ÇØ »ýü¿¡ Åõ¿©Çϴ Ç׿øÀÇ Çϳª. º´¿øÃ¼ ¹× µ¶¼Ò¿¡ ´ëÇÑ ¹æ¾î±â±¸¸¦ °­È­ÇÒ ¸ñÀûÀ¸·Î »ç¿ëµÇ´Â ¹Ì»ý¹°Á¦Á¦¸¦ ¸»ÇÑ´Ù. ÇÁ¶û½ºÀÇ ¹Ì»ý¹°ÇÐÀÚ L. ÆÄ½ºÅ𸣿¡ ÀÇÇÏ¿© Á¦Ã¢µÈ ¿ë¾î·Î¼­, ¾î¶² °¨¿°Áõ¿¡ ´ëÇÏ¿© ÀΰøÀûÀ¸·Î ¸é¿ªÀ» ¾ò±â À§ÇÏ¿© ±× º´¿ø ¹Ì»ý¹° ¶Ç´Â ±× µ¶¼Ò¾×¿¡ Àû´çÇÑ Á¶ÀÛÀ» °¡ÇÏ¿© ¸¸µç °ÍÀ» ¸»ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • subunit vaccine
    ¾Æ´ÜÀ§¹é½Å
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • subunit
    ¼Ò´ÜÀ§, ÇϺδÜÀ§
  • attenuated vaccine
    ¾à(µ¶)È­¹é½Å, ¾àµ¶¹é½Å
  • hepatitis B vaccine
    BÇü°£¿°¹é½Å
  • human diploid cell vaccine
    »ç¶÷µÎ¹è¼ö¼¼Æ÷¹é½Å
  • inactivated vaccine
    ºÒȰ¼ºÈ­¹é½Å, ºñµ¿È­¹é½Å
  • killed vaccine
    »ç¸ê¹é½Å, »ç¹é½Å
  • live vaccine
    »ý¹é½Å
  • mixed vaccine
    È¥ÇÕ¹é½Å
  • rabies vaccine
    ±¤°ßº´¹é½Å
  • recombinant vaccine
    ÀçÁ¶ÇÕ¹é½Å
  • vaccine
    ¹é½Å
  • vaccine rash
    ¹é½Å¹ßÁø
  • vaccine therapy
    ¹é½Å¿ä¹ý
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • subunit
    ¼Ò´ÜÀ§, ¹Ø´ÜÀ§
  • vaccine
    ¹é½Å
  • attenuated vaccine
    µ¶¼º¾àÈ­¹é½Å, ¾àµ¶¹é½Å
  • diphteria and tetanus toxoids and acellular pert vaccine
    °³·®µðÇÇÆ¼
  • inactivated vaccine
    ºÒȰ¼ºÈ­¹é½Å, ºñµ¿È­¹é½Å
  • killed vaccine
    »ç¸ê¹é½Å, »ç¹é½Å
  • live vaccine
    »ý¹é½Å
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • subunit vaccine
    ¾Æ´ÜÀ§¹é½Å
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • subunit
    ¼Ò´ÜÀ§, ¹Ø´ÜÀ§
  • attenuated vaccine
    µ¶¼º¾àÈ­¹é½Å, ¾àµ¶¹é½Å
  • corresponding vaccine
    µ¿Á¾±Õ¹é½Å
  • vaccine exanthem
    Á¾µÎ¹ßÁø
  • inactivated vaccine
    ºÒȰ¼ºÈ­¹é½Å, ºñµ¿È­¹é½Å
  • internal image vaccine
    ³»ºÎ¿µ»ó¹é½Å, °³º°Æ¯ÀÌÇü¹é½Å
  • killed vaccine
    »ç¸ê¹é½Å
  • live vaccine
    »ý¹é½Å
  • live vaccine virus
    »ý¹é½Å¹ÙÀÌ·¯½º
  • mixed vaccine
    È¥ÇÕ¹é½Å
  • recombinant vaccine
    ÀçÁ¶ÇÕ¹é½Å
  • vaccine rash
    ¹é½Å¹ßÁø
  • vaccine therapy
    ¹é½Å¿ä¹ý
  • vaccine
    ¹é½Å
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • BCG vaccine
    ºñ½ÃÁö¹é½Å
  • Bacillus Calmette Gue rin vaccine =BCG v.
    BCG ¹é½Å.
  • Coxs vaccine
    ÄÛ½º¿ÎÁø<¹é½Å>
  • DP vaccine
    µðÇǹé½Å
  • DPT vaccine
    µðÇÇÆ¼¹é½Å
  • DTP vaccine
    µðƼÇǹé½Å
  • Sabin vaccine
    ¼¼À̺ó¹é½Å
  • Sabins vaccine
    ¼¼À̺ó¹é½Å.
  • Sabins vaccine
    ¼¼À̺ó Æú¸®¿À¹é½Å
  • Sabins vaccine
    ¼¼À̺ó¹é½Å.
  • Salk vaccine
    ¼ÒÅ©¹é½Å<Æú¸®¿À»ç¹é½Å>
  • Salks vaccine
    ½î¿ÀÅ© Æú¸®¿À¹é½Å
  • Salks vaccine
    ½î¿ÀÅ© Æú¸®·Î¹é½Å
  • anthrax vaccine
    źÀú¹é½Å.
  • antismallpox vaccine
    ¸¶¸¶¹é½Å.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • subunit vaccine
    ¾Æ´ÜÀ§ ¹é½Å
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • influenza subunit vaccine
    ÀÎÇ®·ç¿£ÀÚ ¾Æ´ÜÀ§¹é½Å
  • vaccine, subunit
    ¾Æ´ÜÀ§ ¹é½Å
  • subunit
    ¾Æ´ÜÀ§, ¼Ò´ÜÀ§
  • anthrax vaccine
    źÀú¹é½Å.
  • antismallpox vaccine
    ¸¶¸¶¹é½Å.
  • attenuated vaccine
    µ¶¼º¾àÈ­¹é½Å.
  • attenuated vaccine
    ¾àµ¶[È­]¹é½Å
  • attenuated vaccine
    µ¶¼º¾àÈ­¹é½Å.
  • bacterial vaccine
    ¼¼±Õ¼º ¿ÎÁø<¹é½Å>.
  • cholera vaccine
    ÄÝ·¹¶ó¹é½Å
  • combined vaccine
    È¥ÇÕ(ûèùê)¿ÎÁø.
  • combined vaccine
    º¹ÇÕ¹é½Å
  • corresponding vaccine
    µ¿Á¾±Õ(ÔÒðúж)¹é½Å.
  • cowpox vaccine
    ¿ìµÎ(éÚÔã)¹é½Å.
  • detoxicate vaccine
    °¨µ¶¿ÎÁø.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • autogenous vaccine
    ÀÚ°¡(í»Ê«)¹é½Å
  • inactivated vaccine
    ºÒȰ¼ºÈ­(ÝÕüÀàõûù) ¹é½Å
  • live vaccine
    »ý(ßæ)¹é½Å
  • mixed vaccine
    È¥¼º(ûèà÷)¹é½Å
  • multivalent vaccine
    ´Ù°¡(Òýʤ) ¹é½Å
  • polyvalent vaccine
    ´Ù°¡(Òýʤ) ¹é½Å
  • catalytic subunit
    Ã˸žƴÜÀ§(õºØÚä¬Ó¤êÈ)
  • proteoglycan subunit
    ÇÁ·ÎÅ׿À±Û¶óÀÌÄ­ ¾Æ´ÜÀ§(ä¬Ó¤êÈ)
  • regulatory subunit
    Á¶Àý ¾Æ´ÜÀ§(ðàï½ä¬Ó¤êÈ)
  • ribosomal subunit
    ¶óÀ̺¸¼Ø ¾Æ´ÜÀ§(ä¬Ó¤êÈ)
  • ribosomal subunit exchange
    ¶óÀ̺¸¼Ø ¾Æ´ÜÀ§(ä¬Ó¤êÈ) ±³È¯(Îßüµ)
  • subunit
    ¾Æ´ÜÀ§(ä¬Ó¤êÈ)
  • subunit exchange
    ¾Æ´ÜÀ§ ±³È¯(ä¬Ó¤êÈÎßüµ)
  • subunit model
    ¾Æ´ÜÀ§(ä¬Ó¤êÈ) ¸ðµ¨
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • vaccine
    ¹é½Å, ¿ÎÁø
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CDPS calcium-dependent protease small subunit
FSV feline fibrosarcoma virus; forward stroke volume; functional subunit
NFATp pre-existing subunit of nuclear factor of activated T [cells]
SCN1A sodium channel, neuronal alpha-subunit type 1
SU salicyluric acid; secretory unit; sensation unit; solar urticaria; sorbent unit; spectrophotometric ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BPV Bordatella pertussis vaccine
DTP Diphtheria-tetanus-pertussis vaccine
Hib Haemophilus influenzae type b vaccine
HDCV Human Diploid Cell Vaccine
IPV Inactivated Polio-Vaccine
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • subunit
    ¾Æ´ÜÀ§
  • anticaries vaccine
    Ç׿ì½Ä ¿ÎÁø
  • antiplaque vaccine
    Ç×ġŠ¿ÎÁø
  • cholera vaccine
    ÄÝ·¹¶ó ¹é½Å
    ºÒȰ¼ºÈ­ cholerarbsÀ» »ç¿ëÇÑ cholera¿ë ¹é½Å. Á¢Á¾À» ÇØµµ °¨¿° ¿¹¹æ·ÂÀº ºÒÃæºÐÇÏ¿© ¿ÏÀüÇÑ È¿°ú´Â ±â´ëÇÒ ¼ö ¾ø´Ù.
  • corresponding vaccine
    µ¿Á¾ ±Õ ¹é½Å
  • herpes type I vaccine
    Á¦1Çü Æ÷Áø ¹é½Å
  • influenza vaccine
    ÀÎÇ÷翣ÀÚ ¹é½Å
    ÀÎÇ÷翣ÀÚÀÇ ¿¹¹æ¿¡ ¾²ÀÌ´Â ¹é½Å. ´Þ°¿ ¹è¾ç¿¡ ÀÇÇØ Áõ½Ä½ÃŲ ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½º¿¡¼­ ´Þ°¿ ¼ººÐÀ» Á¦°ÅÇϰí, Æ÷¸£¸»¸°À» °¡ÇØ °¨¿°·ÂÀ» ¾ø¾Ø °ÍÀÌ´Ù. À¯ÇàÇÏ´Â ¹ÙÀÌ·¯½ºÀÇ Çü°ú ¹é½ÅÀÇ ¹ÙÀÌ·¯½ºÀÇ ÇüÀÌ ¸ÂÁö ¾ÊÀ¸¸é È¿°ú°¡ ÀûÀ¸¹Ç·Î, Ç×»ó ÃÖ±Ù¿¡ À¯ÇàÇÑ 2¡­3°³ À¯ÇüÀÇ »õ·Î¿î ¹ÙÀÌ·¯½º·Î Á¦Á¶µÈ´Ù. Á¦Ç°Àº ¹«»ö Åõ¸íÇÑ ¾×À¸·Î, ¹ÐºÀÇÏ¿© 2¡­5 ¡É¿¡¼­ º¸Á¸µÈ´Ù. À¯È¿ ±â°£Àº °ËÁ¤ ÇÕ°ÝÇÑ ³¯·ÎºÎÅÍ 1³â 6°³¿ùÀ̸ç, 1ȸÀÇ ¾çÀº 15¼¼ ÀÌ»óÀº 0.5 cc, 6¡­15¼¼ ¹Ì¸¸Àº 0.3 cc, 1¡­6¼¼ ¹Ì¸¸Àº 0.2 cc, 1¼¼ ¹Ì¸¸Àº 0.1 ccÀÌ´Ù. ºÎÀÛ¿ëÀº Áֻ縦 ¸ÂÀº ÀÚ¸®°¡ ¾à°£ º×°í ¾ÆÇÁ°Å³ª, ÀϽÃÀûÀÎ ¹ß¿­À̳ª °¡º­¿î °¨±â Áõ¼¼°¡ ³ªÅ¸³¯ ¼ö Àִµ¥, ¿°·ÁÇÒ °ÍÀº ¸ø µÈ´Ù. ´Ù¸¸, ´Þ°¿ ¾Ë·¹¸£±âÀÎ »ç¶÷Àº Áֻ縦 ÇÇÇϰí, Áöº´ÀÌ ÀÖ´Â »ç¶÷Àº ÀÇ»ç¿Í »ó´ãÇÑ´Ù. ¿¹¹æ Á¢Á¾ÀÇ È¿°ú´Â ÁÖ»ç ÈÄ 2ÁÖ°£ÀÌ Áö³ª¾ß ³ªÅ¸³ª¸ç, 3¡­6°³¿ù °£ Áö¼ÓÇϹǷÎ, ¸Å³â À¯Çà±â¿¡ ¾Õ¼­ 10¡­11¿ù¿¡ Áֻ縦 ¸Â´Â °ÍÀÌ ÁÁ´Ù.
  • killed vaccine
    »ç¹é½Å
  • live vaccine
    »ý ¹é½Å
  • mixed vaccine
    È¥ÇÕ ¹é½Å
    µÎ Á¾·ù ÀÌ»óÀÇ ¿¹¹æÁ¢Á¾ Àç·á¸¦ È¥ÇÕÇÑ ¹é½Å. È¥ÇÕÇÔÀ¸·Î½á °¢ ¼ººÐÀÇ ¸é¿ª¿ø¼º¿¡ °¨¼ÕÀÌ ¾ø´Â °æ¿ì ÇàÇÏ¿©Áø´Ù. °¡Àå º¸ÆíÀûÀ¸·Î ¾²À̰í ÀÖ´Â °Í¿¡´Â ÀåÆ¼Çª½º¿Í ÆÄ¶óƼǪ½ºÀÇ È¥ÇÕ ¹é½Å, ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½ºÀÇ AÇü°ú BÇüÀÇ È¥ÇÕ ¹é½Å µîÀÌ ÀÖ´Ù. ÀåÆ¼Çª½º, ÆÄ¶óƼǪ½º È¥ÇÕ ¹é½ÅÀº ÀåÆ¼Çª½º±Õ°ú A±Õ ¹× ÆÄ¶óƼǪ½º B±ÕÀ» »ì±ÕÇÏ¿© ÀÏÁ¤ÇÑ ºñÀ²·Î È¥ÇÕÇÑ °ÍÀ¸·Î¼­, ÇÇÇÏ ÁÖ»ç ¶Ç´Â Çdz» ÁÖ»çÇÑ´Ù.
  • Nicolle-Blaizot's vaccine
    ´ÏÄÝ, ºí·¹ÀÌÁ¶ ¿ÎÁø
    ÀÓ±ÕÀ¸·Î ¸¸µç ÀÓÁú ¿ÎÁø.
  • oral poliovirus vaccine
    ¼Ò¾Æ¸¶ºñ °æ±¸ ¹é½Å, Æú¸®¿À °æ±¸ ¹é½Å
  • polio vaccine
    ¼Ò¾Æ ¸¶ºñ ¹é½Å
    ¼Ò¾Æ ¸¶ºñÀÇ ¿¹¹æÀ» À§ÇÏ¿© ¾²ÀÌ´Â ¸é¿ª¿ø.
  • rabies vaccine
    ±¤°ßº´ ¹é½Å
    ±¤°ßº´ÀÇ ¹ßº´°ú ¿¹¹æÀ» ¸ñÀûÀ¸·Î °³¹ßµÈ ¹é½Å. 1884³â ÇÁ¶û½ºÀÇ L. ÆÄ½ºÅ𸣰¡ ¼§º£¸¦¶û
  • rubella vaccine
    dzÁø ¹é½Å
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
subunit vaccine <pharmacology> A vaccine composed of a purified antigenic determinant that is separated from the disease-causing organism.
(06 Mar 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
gamma subunit, cGMP phosphodiesterase <enzyme> Isolated from canine retinal rod photoreceptor cells; genbank u49359
Registry number: EC 3.1.14.-
Synonym: pde-gamma, pdegamma, cgmp-pde gamma subunit
(26 Jun 1999)
glycoprotein hormones, alpha subunit A non-covalently bound subunit of the glycoprotein hormones tsh, fsh, lh, and hcg which originates in the anterior pituitary gland and placenta. This subunit is virtually identical in structure and indistinguishable by radioimmunoassay in all of the above glycoproteins. It is present in both men and women, but is elevated in postmenopausal women and in patients with hypothyroidism, uraemia and malignant tumours. The alpha subunit may be involved directly in recognition of certain receptors.
(12 Dec 1998)
ribulose-1,5-bisphosphate carboxylase-oxygenase large subunit epsilonN-methyltransferase <enzyme> An aspect of EC 2.1.1.43; trimethylates lys-14 of rubisco
Registry number: EC 2.1.1.-
Synonym: rubisco lsmt, rubisco large subunit lysine n-methyltransferase
(26 Jun 1999)
cholera toxin, B subunit-horseradish peroxidase <chemical> Conjugate of horseradish peroxidase and cholera toxin
Synonym: bhrp, horseradish peroxidase-cholera toxin b subunit, cholera toxin-horseradish peroxidase, horseradish peroxidase-cholera toxin, ib4-hrp
(26 Jun 1999)
chorionic gonadotropin, beta subunit, human The beta subunit of human chorionic gonadotropin. It is used as a clinical marker to facilitate early detection of normal pregnancy and significantly contributes to the diagnosis of various pregnancy-related disorders, such as ectopic pregnancy, spontaneous abortion, hydatidiform mole, choriocarcinoma, or trisomy 21. Further, determination of this marker is immensely helpful to guide curative intervention in testicular cancer. Other possible clinical uses includes as a marker of cancers of the bladder, pancreas, or biliary tract. (scan j clin lab invest suppl 1993;216:97-104)
(12 Dec 1998)
phycocyanin alpha-subunit phycocyanobilin lyase <enzyme> Cleaves thioether bond attaching phycocyanobilin to the alpha subunit of phycocyanin; product of the cpce and cpcf genes of synechococcus
Registry number: EC 4.4.-
Synonym: phycocyanobilin lyase
(26 Jun 1999)
phycoerythrocyanin alpha-subunit phycobiliviolin lyase <enzyme> Shows high degree of homology to phycocyanobilin lyase
Registry number: EC 4.4.-
Synonym: phycobiliviolin lyase, pece protein, pecf protein, pec alpha-subunit phycobiliviolin lyase
(26 Jun 1999)
signal peptide p25-subunit IV cytochrome oxidase <chemical> Similar in action to melittin
Synonym: p25 presequence peptide-cytochrome oxidase, pre-ctox p25
(26 Jun 1999)
subunit <cell biology> Components from which a structure is built, thus myosin has six subunits, microtubules are built of tubulin subunits. In some cases it may be more informative to speak of protomers.
(06 Mar 1998)
acellular vaccine <immunology, pharmacology, virology> Vaccine consisting of antigenic parts of cells.
(13 Nov 1997)
adjuvant vaccine A vaccine that contains an adjuvant; most often the antigen (immunogen) is included in a water-in-oil emulsion (Freund incomplete type adjuvant), or is adsorbed onto an inorganic gel (alum, aluminum hydroxide or phosphate).
(05 Mar 2000)
aqueous vaccine A vaccine having a liquid vehicle (e.g., physiological salt solution) as distinguished from an emulsion.
(05 Mar 2000)
attenuated vaccine Live pathogens that have lost their virulence but are still capable of inducing a protective immune response to the virulent forms of the pathogen, e.g., Sabin polio vaccine.
(05 Mar 2000)
autogenous vaccine A vaccine made from a culture of the patient's own bacteria.
(05 Mar 2000)
bacillus Calmette-Guerin vaccine <drug> Live attenuated vaccine for tuberculosis. For groups and health care workers in high endemic areas. Not to be given to individuals with HIV infection.
(15 Nov 1997)
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
subunit vaccine A vaccine composed primarily of antigenic proteins that cannot cause disease.
Ãâó: www.biobasics.gc.ca/english/View.asp
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • subunit
    ¾Æ´ÜÀ§;¼­ºêÀ¯´ÏÆ®(»ýüÀÔÀÚ(°íºÐÀÚ)¸¦ ÀÌ·ç´Â ±âº» ´ÜÀ§)
  • vaccine
    ¿ìµÎÁ¾
  • Sabin vaccine
    ¼¼À̺ó ¹é½Å(¼Ò¾Æ¸¶ºñ »ý ¹é½Å)
  • Salk vaccine
    ¼ÒÅ©¹é½Å(¼Ò¾Æ¸¶ºñ ¿¹¹æ¿ë)
  • vaccine
    ¿ìµÎÁ¾;¹é½Å
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á